Advertisement
CRCA vs SSO
Which ETF would AI Choose? ProShares Ultra CRCL (CRCA) vs. ProShares Ultra S&P500 (SSO)
Key Takeaways
- Both ETFs are leveraged products from ProShares that seek 2x daily returns, but CRCA targets a single stock while SSO provides exposure to the broad S&P 500 index.
- CRCA focuses on Circle Internet Group, Inc. (CRCL), a fintech company in the stablecoin and blockchain space, resulting in concentrated thematic exposure with higher volatility potential.
- SSO delivers amplified exposure to 500 large-cap U.S. companies across multiple sectors, offering greater diversification compared to CRCA’s single-asset strategy.
- Expense ratios are similar, with CRCA at 0.95% and SSO at 0.84%, though SSO’s larger scale supports tighter liquidity characteristics typical of established leveraged ETFs.
- CRCA represents a narrow, high-risk thematic bet on digital currency infrastructure, whereas SSO aligns with broad U.S. equity market trends and sector rotation dynamics.
- Both funds employ daily rebalancing and are designed for short-term tactical use rather than long-term buy-and-hold strategies due to compounding effects in volatile markets.
Introduction
ProShares Ultra CRCL (CRCA) and ProShares Ultra S&P500 (SSO) both employ 2x daily leverage but pursue markedly different strategies. CRCA concentrates exposure on a single fintech name tied to stablecoins, while SSO amplifies broad large-cap U.S. equity performance. Investors comparing these ETFs often seek to understand how concentrated thematic leverage stacks up against diversified market beta in the current environment of shifting interest rates and technology adoption trends.
ProShares Ultra CRCL (CRCA) Overview
ProShares Ultra CRCL (CRCA) seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of Class A common shares of Circle Internet Group, Inc. (CRCL). The fund is non-diversified and primarily provides leveraged exposure to this single holding through derivatives. It launched in August 2025 with an expense ratio of 0.95%. As a thematic leveraged product, CRCA offers targeted access to the stablecoin and blockchain infrastructure sector without requiring margin accounts. Its structure relies on daily resets, making it suitable for short-term tactical positioning rather than extended holding periods.
ProShares Ultra S&P500 (SSO) Overview
ProShares Ultra S&P500 (SSO) seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the S&P 500 index. The ETF uses swaps, futures, and other derivatives to achieve its leverage while holding a diversified basket approximating the index’s 500 large-cap constituents. Launched in June 2006, SSO carries an expense ratio of 0.84%. It provides broad exposure across technology, financial services, healthcare, and other sectors. Like other daily-reset leveraged ETFs, SSO resets exposure each trading day and is positioned for short-term market timing rather than long-term core allocation.
Industry and Thematic Backdrop
The comparison occurs against a backdrop of evolving U.S. equity markets influenced by artificial intelligence adoption, stablecoin regulatory developments, and monetary policy expectations. CRCA’s underlying focus on Circle Internet Group, Inc. (CRCL) ties it to digital asset infrastructure and payments innovation, where regulatory clarity and institutional adoption act as key catalysts. SSO tracks the broader S&P 500, which benefits from earnings growth in technology leaders and sector rotation driven by economic data and interest rate paths. Both face risks from market volatility, leverage decay over multiple days, and macroeconomic shifts that can amplify or erode daily returns.
Performance and Positioning Comparison
In recent market cycles, SSO has generally tracked amplified movements of the S&P 500, benefiting from broad participation in large-cap gains while experiencing corresponding drawdowns. CRCA’s performance has been more idiosyncratic, reflecting the price action of its single underlying holding and exhibiting greater dispersion from broad market trends. SSO’s diversified holdings provide relative stability in sector rotations, whereas CRCA’s concentrated profile introduces higher sensitivity to company-specific news and fintech sentiment. Over longer periods, compounding effects from daily resets can cause both funds to deviate from simple 2x multiples, with SSO typically showing more consistent alignment to overall market direction.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening.
Tickeron AI Verdict
Based on observable structural factors, Tickeron’s AI would likely assign a higher probability of favorability to ProShares Ultra S&P500 (SSO) for investors seeking leveraged equity exposure. Its broad diversification across hundreds of holdings, lower expense ratio, longer track record, and alignment with overall market momentum provide a more balanced risk profile compared to the concentrated single-stock leverage of ProShares Ultra CRCL (CRCA). This assessment reflects relative positioning strength rather than any guarantee of future results.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRCA is a Hold and SSO is a Hold.
Momentum Indicator for CRCA turns negative, indicating new downward trend
CRCA saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator turned negative. In 24 of the 24 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for CRCA turned negative on October 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 8 similar instances when the indicator turned negative. In 8 of the 8 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
The 10-day moving average for CRCA crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 2 of 2 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRCA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CRCA entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +11.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRCA advanced for three days, in 50 of 57 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
CRCA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
SSO's Stochastic Oscillator stays in oversold zone for 1 day
Be on the lookout for a price bounce soon.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +3.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where SSO advanced for three days, in 314 of 351 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
SSO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SSO as a result. In 61 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for SSO turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 47 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.
SSO moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for SSO crossed bearishly below the 50-day moving average on October 26, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SSO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for SSO entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
| CRCA | SSO | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 3 days ago 87% | 3 days ago 90% |
| Momentum ODDS (%) | 3 days ago 90% | 3 days ago 82% |
| MACD ODDS (%) | 3 days ago 90% | 3 days ago 89% |
| TrendWeek ODDS (%) | 3 days ago 90% | 3 days ago 85% |
| TrendMonth ODDS (%) | 3 days ago 90% | 3 days ago 88% |
| Advances ODDS (%) | 5 days ago 88% | 5 days ago 89% |
| Declines ODDS (%) | 3 days ago 90% | 7 days ago 84% |
| BollingerBands ODDS (%) | 3 days ago 89% | 3 days ago 90% |
| Aroon ODDS (%) | 3 days ago 90% | 3 days ago 90% |
Advertisement